GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Aarti Drugs Ltd

Aarti Drugs Board Meeting on July 31, 2026 to Consider Q1 FY27 Results

RESULTS ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 24 Jul 2026, 07:25 PM IST  ·  BSE ID: d51bfe7c-2cc5-44ff-84ee-e98b2242b025
View Original BSE Filing (PDF)
💡
In Simple Terms
Aarti Drugs' board will meet on July 31, 2026, to announce its latest quarterly financial results.
🤖 AI Summary
  • Aarti Drugs Ltd Board of Directors meeting scheduled for Friday, July 31, 2026.
  • The Board will consider and approve Audited Financial Results for the Quarter ended June 30, 2026.
  • Trading window remains closed until 48 hours post-declaration of the financial results.
  • Intimation regarding trading window closure was previously issued on June 26, 2026.
👥 What This Means For Shareholders
✅
Action Required
Shareholders are not required to take any action based on this intimation of a board meeting.
👤
Who Is Affected
All shareholders will be affected by the upcoming financial results, which will provide an update on the company's performance for Q1 FY27. The trading window closure affects all shareholders trading company shares.
🔍
Management Signal
The scheduling of the board meeting indicates management's adherence to regulatory requirements for timely disclosure of financial results.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Aarti Drugs' Audited Financial Results for the quarter ended June 30, 2026.
Trading window re-opening date, 48 hours after financial results declaration.
Any subsequent disclosures or announcements following the July 31, 2026 board meeting.
LOW RISK This filing is a routine intimation of a board meeting for financial results, carrying no immediate risks.
💡 Investor Takeaway
Aarti Drugs Ltd has scheduled a Board Meeting on July 31, 2026, to approve its Audited Financial Results for the Quarter ended June 30, 2026. The trading window remains closed until 48 hours after these Q1 FY27 results are publicly declared.
📅 Company Track Record
Aarti Drugs reported FY26 Consolidated Profit of Rs. 19,494 lakhs on May 15, 2026, which was up 16.09% YoY. This upcoming meeting will disclose the first quarter results for FY27.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is Aarti Drugs Ltd's next Board Meeting scheduled?
The next Board Meeting of Aarti Drugs Ltd is scheduled for Friday, July 31, 2026.
What is the purpose of the Aarti Drugs Board Meeting on July 31, 2026?
The purpose of the Board Meeting on July 31, 2026, is to consider, approve, and take on record the Audited Financial Results for the Quarter ended June 30, 2026.
Is the trading window for Aarti Drugs Ltd shares open?
No, the trading window for Aarti Drugs Ltd shares remains closed until the expiry of 48 hours after the declaration of the financial results for the quarter ended June 30, 2026.
Where can I find more information about this Aarti Drugs filing?
The information is also available on the company's website: www.aartidrugs.com.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.